55 reports

  • Global Market Share for Influenza (Antivirals), by Brand, 2016 (%) 113
  • Table 49 Global Market Share for Influenza (Antivirals), by Brand, 2016 (%) 113

• The global market for infectious disease treatments totaled $64.8 billion in 2017. • The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022. • The global market for therapeutics in infectious disease treatments totaled $48.9 billion in 2017. • The market should total...

  • Infectious Disease
  • Pathology
  • World
  • manufacturing.

Albany Molecular Research Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Healthcare
  • Pharmaceutical
  • United States
  • M&A
  • AMRI

You can easily book an appointment with one online.

  • Diagnostics
  • Influenza
  • Laboratory
  • Point Of Care Testing
  • Alere Inc.
  • CC-42344 - DRUG PROFILE

Its novel antiviral therapeutics is used in treatments for serious and chronic viral diseases.

  • Influenza
  • Pathology
  • Therapy
  • Vaccine
  • NanoViricides, Inc.
  • PARTNERSHIPS

Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases.It has four product candidates in clinical development which address viral infections, namely, vapendavir, oral broad spectrum capsid...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Aviragen Therapeutics, Inc.
  • SEP 21, 2017: BIOCRYSTS RAPIVAB (PERAMIVIR INJECTION) RECEIVES FDA APPROVAL FOR A PEDIATRIC INDICATION
  • LANINAMIVIR - DRUG PROFILE

IT ENABLES AMRI TO DEVELOP AND MANUFACTURE THE INFLUENZA ANTIVIRAL PRODUCTS.

  • Influenza
  • Pathology
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Daiichi Sankyo Company Ltd - History

In May, Daiichi Sankyo Company, Limited entered into a cooperative sales agreement with The Chemo-Sero-Therapeutic Research Institute for its influenza HA vaccine " Kaketsuken" .

  • Healthcare
  • Pharmaceutical
  • World
  • Company Financials
  • Daiichi Sankyo Company

You can easily book an appointment with one online.

  • Immunochemistry Test
  • Laboratory
  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • Roche Group
  • Clinical Trial profile. 979 Trial Title
  • Clinical Trial profile. 1056 Trial Title

Orthomyxoviridae Infections Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Orthomyxoviridae Infections Global Clinical Trials Review, H1, 2018" provides an overview of Orthomyxoviridae Infections clinical trials scenario.This report provides top line data relating...

  • Clinical Trial
  • Infectious Disease
  • Influenza
  • Pharmaceutical
  • Vaccine
  • PARTNERSHIPS
  • PARTNERSHIPS

It enables AMRI to develop and manufacture the influenza antiviral products.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • AMRI
  • CC-42344 - DRUG PROFILE

CF-## elicits antiviral activity by inhibiting hemagglutinin.

  • Healthcare
  • Influenza
  • Pathology
  • Therapy
  • Vaccine
  • 09/21/2017: BIOCRYSTS RAPIVAB (PERAMIVIR INJECTION) RECEIVES FDA APPROVAL FOR A PEDIATRIC INDICATION

" This approval represents the first new influenza antiviral for pediatric use in over ## years, " said Jon P.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • BioCryst Pharmaceuticals, Inc.

Involves in the manufacture of diagnostic products and tests for fusion-inhibiting entry-inhibiting influenza antiviral drugs and antiphospholipid antibody assays.

  • Autoimmune Disease
  • Diagnostics
  • World
  • EUROIMMUN AG
  • Roche Group
  • LANINAMIVIR - DRUG PROFILE
  • LANINAMIVIR - DRUG PROFILE

It enables AMRI to develop and manufacture the influenza antiviral products.

  • Influenza
  • Pathology
  • Pharmaceutical
  • Therapy
  • Vaccine

Tamiflu can also reduce the chance of getting the flu in people ## year and older.

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States
  • Genentech, Inc.

Tamiflu can also reduce the chance of getting the flu in people ## year and older.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • Pharmacy
  • United States

Tamiflu can also reduce the chance of getting the flu in people ## year and older.

  • Healthcare
  • Pharmaceutical
  • Pharmacy
  • United States
  • Company Financials

Tamiflu can also reduce the chance of getting the flu in people ## year and older.

  • Healthcare
  • Pharmaceutical
  • Pharmacy
  • United States
  • Company Financials
  • Dec 21, 2012: Sarepta Therapeutics Enters Into Clinical Trial Agreement With NIH For Further Development Of Influenza Drug AVI-7100
  • Dec 21, 2012: Sarepta Therapeutics Enters Into Clinical Trial Agreement With NIH For Further Development Of Influenza Drug AVI-7100

Our agreement signifies the importance of developing new treatment options for influenza with novel mechanisms of action given the limitations of currently available influenza antivirals.

  • Influenza
  • Pathology
  • Pharmaceutical
  • Therapy
  • Vaccine
  • SMALL MOLECULES TO ACTIVATE SIRTUIN FOR INFLUENZA - DRUG PROFILE
  • CC-42344 - DRUG PROFILE

The target Influenza viruses are Influenza A viruses, the transmembrane proteins are comprised of one or more different HA subtypes ## -## and / or NA subtypes ## -## ##.

  • Influenza
  • Pathology
  • Pharmaceutical
  • Vaccine
  • BiondVax Pharmaceuticals Ltd.

Antiviral Therapy Targeting Viral Polymerase.

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • World
  • Market Size
  • 9.3 BIBLIOGRAPHY

Antiviral Research; ##(##): ##-## Black S, et al. (2010).

  • Influenza
  • Pathology
  • Pharmaceutical
  • Therapy
  • Vaccine

Tamiflu can also reduce the chance of getting the flu in people ## year and older.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • Pharmacy
  • United States
  • Pharmaceutical Market, Chemical Company of Malaysia, Global, Major Products, 2016

Health Systems in Transition; ##(##): ##-##.

  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Malaysia
  • Southeast Asia
  • SMALL MOLECULES TO ACTIVATE SIRTUIN FOR INFLUENZA - DRUG PROFILE
  • SMALL MOLECULES TO ACTIVATE SIRTUIN FOR INFLUENZA - DRUG PROFILE

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2018, provides an overview of the Influenza A Virus, H5N1 Subtype Infections...

  • Influenza
  • Pathology
  • Pharmaceutical
  • Vaccine
  • BiondVax Pharmaceuticals Ltd.
  • Aug 09, 2018: Cocrystal Pharma reports 2018 second quarter financial results and provides corporate update
  • May 11, 2018: Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update

Complete preclinical IND-enabling studiesandInitiate Phase ## study evaluating CC-## for the treatment of influenza in Q## 2018.

  • Cocrystal Pharma, Inc.

GLOBAL INFLUENZA THERAPEUTICS MARKET INFLUENZA, COMMONLY KNOWN AS ' FLU', IS ONE OF THE MOST CONTAGIOUS RESPIRATORY DISORDERS CAUSED BY THE INFLUENZA VIRUS.

  • Antiviral
  • HIV AIDS
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Dec 21, 2012: Sarepta Therapeutics Enters Into Clinical Trial Agreement With NIH For Further Development Of Influenza Drug AVI-7100

Our agreement signifies the importance of developing new treatment options for influenza with novel mechanisms of action given the limitations of currently available influenza antivirals.

  • Influenza
  • Therapy
  • Vaccine
  • Product Initiative
  • Novavax, Inc.

Also embedded in the lipid membrane is the M## protein, which is the target of the antiviral adamantanes - amantadine and rimantadine.

  • Child Health
  • Influenza
  • Pathology
  • Vaccine
  • Northern Europe
  • PARTNERSHIP - DEAL REPORTS

Industry Address Country Website Phone number Pharmaceuticals and Healthcare--> Pharmaceuticals-- > Pharmaceutical Manufacturers Pharmaceuticals and Healthcare--> Therapy Area-- > Infectious Diseases--> Antivirals--> Respiratory Antivirals Pharmaceuticals and Healthcare

  • Pharmaceutical
  • Therapy
  • United States
  • M&A
  • AMRI